tradingkey.logo

Inspire Veterinary Partners Inc

IVP
0.034USD
0.0000.00%
Cierre 02/06, 16:00ETCotizaciones retrasadas 15 min
225.42KCap. mercado
PérdidaP/E TTM

Inspire Veterinary Partners Inc

0.034
0.0000.00%

Más Datos de Inspire Veterinary Partners Inc Compañía

Inspire Veterinary Partners, Inc. owns and operates veterinary hospitals throughout the United States. The Company specializes in small animal general practice hospitals which serve all types of companion pets, emphasizing canine and feline breeds and including equine care. Services provided at its hospitals include preventive care for companion animals, consisting of annual health exams, including parasite control; dental health; nutrition and body condition counseling; neurological examinations; radiology; bloodwork; skin and coat health and many breed specific preventive care services. Surgical offerings include all soft tissue procedures, such as spays and neuters, mass removals, splenectomies and can also include gastropexies, orthopedic procedures and other types of surgical offerings based on a doctor’s training. In many locations, additional means of care and alternative procedures are also offered, such as acupuncture, chiropractic and other health and wellness offerings.

Información de Inspire Veterinary Partners Inc

Símbolo de cotizaciónIVP
Nombre de la empresaInspire Veterinary Partners Inc
Fecha de salida a bolsaAug 30, 2023
Director ejecutivoCarr (Kimball)
Número de empleados113
Tipo de seguridadOrdinary Share
Fin del año fiscalAug 30
Dirección780 Lynnhaven Pkwy #400
CiudadVIRGINIA BEACH
Bolsa de valoresNASDAQ OMX - NASDAQ BASIC
PaísUnited States of America
Código postal23452
Teléfono17572883088
Sitio Webhttps://www.inspirevet.com/
Símbolo de cotizaciónIVP
Fecha de salida a bolsaAug 30, 2023
Director ejecutivoCarr (Kimball)

Ejecutivos de Inspire Veterinary Partners Inc

Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Mr. Kimball Carr
Mr. Kimball Carr
Chairman of the Board, President, Chief Executive Officer
Chairman of the Board, President, Chief Executive Officer
11.00
--
Mr. Charles Stith Keiser
Mr. Charles Stith Keiser
Director
Director
10.00
--
Dr. Erinn Thomas-Mackey
Dr. Erinn Thomas-Mackey
Director
Director
2.00
--
Mr. Richard Paul Frank
Mr. Richard Paul Frank
Chief Financial Officer
Chief Financial Officer
--
--
Ms. Anne Murphy
Ms. Anne Murphy
Independent Director
Independent Director
--
--
Mr. Timothy Watters
Mr. Timothy Watters
Independent Director
Independent Director
--
--
Mr. Larry Alexander
Mr. Larry Alexander
Independent Director
Independent Director
--
--
Mr. Phillip Balatsos
Mr. Phillip Balatsos
Independent Director
Independent Director
--
--
Ms. Alexandra Quatri
Ms. Alexandra Quatri
Vice President of Medical Operations
Vice President of Medical Operations
--
--
Ms. Laura Johnson
Ms. Laura Johnson
Vice President of Operations
Vice President of Operations
--
--
Ver más
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Mr. Kimball Carr
Mr. Kimball Carr
Chairman of the Board, President, Chief Executive Officer
Chairman of the Board, President, Chief Executive Officer
11.00
--
Mr. Charles Stith Keiser
Mr. Charles Stith Keiser
Director
Director
10.00
--
Dr. Erinn Thomas-Mackey
Dr. Erinn Thomas-Mackey
Director
Director
2.00
--
Mr. Richard Paul Frank
Mr. Richard Paul Frank
Chief Financial Officer
Chief Financial Officer
--
--
Ms. Anne Murphy
Ms. Anne Murphy
Independent Director
Independent Director
--
--
Mr. Timothy Watters
Mr. Timothy Watters
Independent Director
Independent Director
--
--

Desglose de ingresos

La empresa aún no ha revelado los datos relevantes.
La empresa aún no ha revelado los datos relevantes.
Por negocio
Por región
La empresa aún no ha revelado los datos relevantes.

Estadísticas de accionistas

Actualizado: sáb., 7 de feb
Actualizado: sáb., 7 de feb
Accionistas
Tipos de accionistas
Accionistas
Accionistas
Proporción
UBS Financial Services, Inc.
0.10%
DRW Securities, LLC
0.03%
Otro
99.87%
Accionistas
Accionistas
Proporción
UBS Financial Services, Inc.
0.10%
DRW Securities, LLC
0.03%
Otro
99.87%
Tipos de accionistas
Accionistas
Proporción
Investment Advisor
0.13%
Otro
99.87%

Participación institucional

Actualizado: jue., 1 de ene
Actualizado: jue., 1 de ene
Periodo del informe
Número de instituciones
Acciones mantenidas
Proporción
Cambio
2025Q4
29
425.59K
0.13%
+331.09K
2025Q3
30
85.70K
2.35%
-162.35K
2025Q2
36
227.92K
10.75%
+186.48K
2025Q1
37
233.23K
11.15%
+199.50K
2024Q4
35
26.63K
1.96%
+14.11K
2024Q3
29
12.19K
10.24%
+9.83K
2024Q2
26
1.53K
5.46%
+829.00
2024Q1
24
680.00
3.62%
+167.00
2023Q4
22
514.00
27.03%
+264.00
2023Q3
15
280.00
16.84%
+280.00

Actividad de los accionistas

Nombre
Acciones mantenidas
Proporción
Cambio
Cambio %
Fecha
UBS Financial Services, Inc.
12.15K
0.34%
+200.00
+1.67%
Jun 30, 2025
DRW Securities, LLC
95.11K
0.25%
+95.11K
--
Sep 30, 2025
Geode Capital Management, L.L.C.
10.62K
0.29%
+580.00
+5.78%
Jun 30, 2025
Citi Investment Research (US)
5.29K
0.01%
+5.29K
--
Sep 30, 2025
Tower Research Capital LLC
2.72K
0.08%
+554.00
+25.58%
Jun 30, 2025
Wells Fargo Advisors
15.00
0%
+11.00
+275.00%
Jun 30, 2025
Lawrence (Alexander)
1.00
0%
--
--
Aug 08, 2025
Ver más

ETFs relacionados

Nombre
Proporción
Sin datos

Dividendos

Un total de 0.00 USD se ha distribuido en dividendos durante los últimos 5 años.
Fecha
Dividendos
Fecha de registro
Fecha de pago
Fecha ex-dividendo
Sin datos

División de acciones

Fecha
Fecha ex-dividendo
Tipo
Relación
Jan 23, 2025
Merger
25→1
Jan 23, 2025
Merger
25→1
Jan 23, 2025
Merger
25→1
Jan 23, 2025
Merger
25→1
Apr 17, 2024
Merger
100→1
Apr 17, 2024
Merger
100→1
Fecha
Fecha ex-dividendo
Tipo
Relación
Jan 23, 2025
Merger
25→1
Jan 23, 2025
Merger
25→1
Jan 23, 2025
Merger
25→1
Jan 23, 2025
Merger
25→1
Apr 17, 2024
Merger
100→1
Apr 17, 2024
Merger
100→1
Apr 17, 2024
Merger
100→1
Apr 17, 2024
Merger
100→1
KeyAI